Kyntra Bio Inc (KYNB): Next-Year EPS Estimate 29.95%
As of 2026-06-04, Kyntra Bio Inc (KYNB) has a next-year EPS growth estimate of 29.95%.
Analyst estimates for KYNB have remained steady in the most recent observable window, with next-year EPS growth projected at 29.95%. Current-year growth stands at -130.61%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 29.95%
- EPS growth this year
- -130.61%
- EPS next quarter (est)
- -$3.27
- Last price
- $6.81
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 29.95% | -130.61% | -$3.27 | $6.81 |
| 2026-06-03 | 29.95% | -130.61% | -$3.27 | $6.81 |
| 2026-06-02 | 29.95% | -130.61% | -$3.27 | $6.84 |
| 2026-06-01 | 29.95% | -130.61% | -$3.27 | $6.90 |
| 2026-05-31 | 29.95% | -130.62% | -$3.27 | $6.90 |
| 2026-05-28 | 29.95% | -130.62% | -$3.27 | $7.02 |
| 2026-05-27 | 29.95% | -130.62% | -$3.27 | $7.01 |
| 2026-05-26 | 29.95% | -130.62% | -$3.27 | $6.85 |
| 2026-05-25 | 29.95% | -130.62% | -$3.27 | $6.99 |
| 2026-05-24 | 29.95% | -130.62% | -$3.27 | $6.99 |
| 2026-05-21 | 29.95% | -130.62% | -$3.27 | $6.94 |
| 2026-05-20 | 29.95% | -130.62% | -$3.27 | $6.95 |
| 2026-05-19 | 29.95% | -130.62% | -$3.27 | $6.80 |
| 2026-05-18 | 29.95% | -130.62% | -$3.27 | $6.83 |
| 2026-05-17 | 29.95% | -130.62% | -$3.27 | $6.82 |
| 2026-05-14 | 29.95% | -130.62% | -$3.27 | $7.01 |
| 2026-05-13 | 29.95% | -130.62% | -$3.27 | $7.01 |
| 2026-05-12 | 29.95% | -130.62% | -$3.27 | $7.22 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Kyntra Bio Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Kyntra Bio Inc (KYNB) has a next-year EPS growth estimate of 29.95%, based on analyst consensus.
What sector and industry does Kyntra Bio Inc belong to?▾
Kyntra Bio Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KYNB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Kyntra Bio Inc (KYNB) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports